← FDA Drug Approvals (Drugs@FDA)

TADALAFIL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD III · Approved 2019-02-05

Drug application

FDA Application #

ANDA209907

Application type

Abbreviated New Drug Application (Generic)

Brand name

TADALAFIL

Generic name

TADALAFIL

Active ingredients

TADALAFIL

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

HETERO LABS LTD III

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2019-02-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown